Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDEA: Early vs. Deferred Voriconazole in Neutropenic Fever
NCT00150345Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jan 2005
- Primary completion
- Apr 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of voriconazole in invasive fungal infection (IFI), sponsored by Pfizer. Started Jan 2005; status: completed.
02
Drugs
voriconazole
03
Conditions
invasive fungal infection (IFI)
Beyond the preview
Go deeper on NCT00150345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00150345.